QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

S&P 500 constituent Stryker Corp. is acquiring Inari Medical in a deal expected to be completed soon, pending final closing...

 plug-power-capri-and-frontline-are-among-top-mid-cap-gainers-last-week-jan-6-10-are-the-others-in-your-portfolio

These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in ...

 btig-downgrades-inari-medical-to-neutral

BTIG analyst Marie Thibault downgrades Inari Medical (NASDAQ:NARI) from Buy to Neutral.

 wells-fargo-downgrades-inari-medical-to-equal-weight-raises-price-target-to-80

Wells Fargo analyst Larry Biegelsen downgrades Inari Medical (NASDAQ:NARI) from Overweight to Equal-Weight and raises the pr...

 william-blair-downgrades-inari-medical-to-market-perform

William Blair analyst Margaret Andrew downgrades Inari Medical (NASDAQ:NARI) from Outperform to Market Perform.

 piper-sandler-maintains-neutral-on-inari-medical-raises-price-target-to-80

Piper Sandler analyst Adam Maeder maintains Inari Medical (NASDAQ:NARI) with a Neutral and raises the price target from $52 ...

 stryker-to-buy-inari-medical-in-5-billion-deal-to-bolster-venous-thromboembolism-position

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a gr...

 canaccord-genuity-downgrades-inari-medical-to-hold-raises-price-target-to-80

Canaccord Genuity analyst William Plovanic downgrades Inari Medical (NASDAQ:NARI) from Buy to Hold and raises the price targ...

 baird-downgrades-inari-medical-to-neutral-lowers-price-target-to-80

Baird analyst David Rescott downgrades Inari Medical (NASDAQ:NARI) from Outperform to Neutral and lowers the price target fr...

 inari-medical-shares-resume-trade
Inari Medical Shares Resume Trade
01/06/2025 20:27:01

Core News & Articles

- Reuters

 truist-securities-maintains-hold-on-inari-medical-raises-price-target-to-63

Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and raises the price target fro...

 oppenheimer-initiates-coverage-on-inari-medical-with-outperform-rating-announces-price-target-of-75

Oppenheimer analyst Steve Lichtman initiates coverage on Inari Medical (NASDAQ:NARI) with a Outperform rating and announces ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION